FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karl-Martin Koch

Research Profile

Procedures

Disorders

Chemicals & Drugs

Objects

Membranes, Artificial

Living Beings

Rats

Anatomy

Co-author Network

Publications

TOP 3
Wilfried Gwinner; Jan Menne; Gerhard Lonnemann; Ferdinand H Bahlmann; Karl-Martin Koch; H Haller
Life-threatening complications of extracorporeal treatment in patients with severe eosinophilia.
Alexander Woywodt; Jens Bahlmann; Marion Haubitz; Hermann Haller; Karl-Martin Koch
From the Prague Spring to a chair in nephrology in Germany: Jan Brod (1912-1985).
Soeren A Gaertner; Ulf Janssen; Tammo Ostendorf; Karl-Martin Koch; Jürgen Floege; Wilfried Gwinner
Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karl-Martin Koch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Wilfried Gwinner; Jan Menne; Gerhard Lonnemann; Ferdinand H Bahlmann; Karl-Martin Koch; H Haller
Life-threatening complications of extracorporeal treatment in patients with severe eosinophilia.
The International journal of artificial organs 2005;28(12):1224-7.
2004: Alexander Woywodt; Jens Bahlmann; Marion Haubitz; Hermann Haller; Karl-Martin Koch
From the Prague Spring to a chair in nephrology in Germany: Jan Brod (1912-1985).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(6):1374-7.
2002: Soeren A Gaertner; Ulf Janssen; Tammo Ostendorf; Karl-Martin Koch; Jürgen Floege; Wilfried Gwinner
Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis.
Journal of the American Society of Nephrology : JASN 2002;13(12):2930-7.
2002: Gerhard Lonnemann; Karl-Martin Koch
Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane.
Journal of the American Society of Nephrology : JASN 2002;13 Suppl 1():S72-7.
2001: Tammo Ostendorf; Uta Kunter; Hermann-Josef Gröne; F Bahlmann; H Kawachi; F Shimizu; Karl-Martin Koch; Nebojsa Janjic; Jürgen Floege
Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis.
Journal of the American Society of Nephrology : JASN 2001;12(5):909-18.
2001: Jörg Radermacher; Ajay Chavan; Jörg S Bleck; A Vitzthum; B Stoess; Michael Gebel; Michael Galanski; Karl-Martin Koch; Hermann Haller
Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.
The New England journal of medicine 2001;344(6):410-7.
2001: Gerhard Lonnemann; Karl-Martin Koch
Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 4():17-22.
2001: Jürgen Floege; J Schäffer; Karl-Martin Koch
Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 4():12-6.
2000: J Schäffer; Wolfgang Burchert; Jürgen Floege; P Gielow; C Kionka; Reinhold P Linke; E H Weiss; stanley shaldon; Karl-Martin Koch
Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.
Kidney international 2000;58(2):873-80.
2000: Gerhard Lonnemann; Jürgen Floege; Volker Kliem; Reinhard Brunkhorst; Karl-Martin Koch
Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(8):1189-93.
1999: Karl-Martin Koch
[Nephrology. Advances and economic restraints].
Deutsche medizinische Wochenschrift (1946) 1999;124(51-52):1559-61.
1999: Gerhard Lonnemann; M Bechstein; S Linnenweber; Michael Burg; Karl-Martin Koch
Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
Kidney international. Supplement 1999;(72):S84-7.
1999: Jan T Kielstein; Rainer H Böger; Stefanie M Bode-Böger; J Schäffer; MM Barbey; Karl-Martin Koch; Jürgen C Frölich
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
Journal of the American Society of Nephrology : JASN 1999;10(3):594-600.
1999: Wilfried Gwinner; J Plasger; RP Brandes; B Kubat; M Schulze; Heinz Regele; D Kerjaschki; CJ Olbricht; Karl-Martin Koch
Role of xanthine oxidase in passive Heymann nephritis in rats.
Journal of the American Society of Nephrology : JASN 1999;10(3):538-44.
1999: Volker Kliem; A Boeck; Ute Eisenberger; R Petersen; Jörg Radermacher; Markus Hiss; M Pethig; Karl-Martin Koch; Björn Nashan; Reinhard Brunkhorst
Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
Transplantation proceedings 1999;31(1-2):1312-3.
1999: Jürgen Floege; S Segerer; J Schäffer; Karl-Martin Koch
[Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease].
Der Internist 1999;40(1):64-9.
1999: J Schäffer; Jürgen Floege; Karl-Martin Koch
[Long-term management of dialysis patients. I. Hypertension and anemia].
Der Internist 1999;40(1):55-63.
1998: Marion Haubitz; S Schellong; U Göbel; H J Schurek; D Schaumann; Karl-Martin Koch; Reinhard Brunkhorst
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Arthritis and rheumatism 1998;41(10):1835-44.
1998: Marion Haubitz; Karl-Martin Koch; Reinhard Brunkhorst
Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(7):1713-8.
1998: OK Eberhard; I Langefeld; Ernst R Kuse; Frank M Brunkhorst; Volker Kliem; Hans J Schlitt; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
Clinical transplantation 1998;12(3):206-11.
1998: G Ehlerding; J Schaeffer; W Drommer; T Miyata; Karl-Martin Koch; Jürgen Floege
Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(6):1465-75.
1998: Volker Kliem; R Petersen; G Ehlerding; D Schaumann; Ute Eisenberger; Karl-Martin Koch; Rudolf Pichlmayr; Reinhard Brunkhorst
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
Transplantation proceedings 1998;30(4):1251-3.
1998: Volker Kliem; T Tiroke; G Ehlerding; OK Eberhard; Matthias Behrend; U Frei; Karl-Martin Koch; Rudolf Pichlmayr; Reinhard Brunkhorst
Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
Transplantation proceedings 1998;30(4):1207-9.
1998: Wilfried Gwinner; U Deters-Evers; RP Brandes; B Kubat; Karl-Martin Koch; M Pape; CJ Olbricht
Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney.
The Journal of physiology 1998;509 ( Pt 2)():599-606.
1998: Jürgen Floege; Michael Burg; Christian Hugo; Katherine L Gordon; H Van Goor; Michael A Reidy; William G Couser; Karl-Martin Koch; R J Johnson
Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis.
Journal of the American Society of Nephrology : JASN 1998;9(5):792-801.
1998: Gerhard Lonnemann; S Linnenweber; Michael Burg; Karl-Martin Koch
Transfer of endogenous pyrogens across artificial membranes?
Kidney international. Supplement 1998;66():S43-6.
1998: S Canaan-Kühl; Tammo Ostendorf; K Zander; Karl-Martin Koch; Jürgen Floege
C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
Kidney international 1998;53(5):1143-51.
1998: S Krautzig; Ulf Janssen; Karl-Martin Koch; Céline Granolleras; S Shaldon
Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(3):552-3.
1998: Jörg Radermacher; M Meiners; C Bramlage; Volker Kliem; Matthias Behrend; Hans J Schlitt; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11(1):3-10.
1998: Marion Haubitz; C Ehlerding; K Kamino; Karl-Martin Koch; Reinhard Brunkhorst
Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases.
Clinical nephrology 1998;49(1):19-23.
1998: Jürgen Floege; Gerhard Lonnemann; D O Stichtenoth; Karl-Martin Koch; Reinhard Brunkhorst
Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(1):187-9.
1997: Volker Kliem; D Schaumann; G Ehlerding; OK Eberhard; Volkmar Lufft; Hans J Schlitt; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
Transplantation proceedings 1997;29(7):2955-7.
1997: Wilfried Gwinner; Ulf Landmesser; RP Brandes; B Kubat; J Plasger; OK Eberhard; Karl-Martin Koch; CJ Olbricht
Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
Journal of the American Society of Nephrology : JASN 1997;8(11):1722-31.
1997: OK Eberhard; Volker Kliem; Gisela Offner; Karl J Oldhafer; J Fangmann; R Pichlmay; Karl-Martin Koch; Reinhard Brunkhorst
Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria.
Clinical transplantation 1997;11(5 Pt 1):415-9.
1997: S Schwalbe; M Holzhauer; J Schaeffer; M Galanski; Karl-Martin Koch; Jürgen Floege
Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
Kidney international 1997;52(4):1077-83.
1997: Marion Haubitz; P Schulzeck; S Schellong; M Schulze; Karl-Martin Koch; Reinhard Brunkhorst
Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis and rheumatism 1997;40(9):1680-4.
1997: Michael Burg; Hermann-Josef Gröne; Karl-Martin Koch; Jürgen Floege
Cationic dextran induces mesangioproliferative nephritis in rats independent of glomerular IgA deposition.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(9):1856-62.
1997: Volker Kliem; M Kolditz; Matthias Behrend; G Ehlerding; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Risk of renal cell carcinoma after kidney transplantation.
Clinical transplantation 1997;11(4):255-8.
1997: OK Eberhard; Marion Haubitz; Frank M Brunkhorst; Volker Kliem; Karl-Martin Koch; Reinhard Brunkhorst
Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
Arthritis and rheumatism 1997;40(7):1250-6.
1997: Michael Burg; Tammo Ostendorf; A Mooney; Karl-Martin Koch; Jürgen Floege
Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Laboratory investigation; a journal of technical methods and pathology 1997;76(4):505-16.
1997: Volker Kliem; Marion Haubitz; G Ehlerding; Björn Nashan; Hans J Schlitt; Karl J Oldhafer; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Outcome of kidney transplantation in patients with systemic autoimmune diseases.
Transplantation proceedings 1997;29(1-2):957-8.
1997: Jürgen Floege; B Hackmann; Volker Kliem; W Kriz; C E Alpers; R J Johnson; K W Kühn; Karl-Martin Koch; Reinhard Brunkhorst
Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease.
Kidney international 1997;51(1):230-43.
1997: Frank Eitner; R Westerhuis; Michael Burg; Birgit Weinhold; Hermann-Josef Gröne; Tammo Ostendorf; Ulrich Rüther; Karl-Martin Koch; A J Rees; Jürgen Floege
Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo.
Kidney international 1997;51(1):69-78.
1996: Volker Kliem; OK Eberhard; Karl J Oldhafer; Hans J Schlitt; Matthias Behrend; D Schaumann; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Transplantation proceedings 1996;28(6):3166-8.
1996: Volker Kliem; U van den Hoff; Reinhard Brunkhorst; Hans L Tillmann; J Flik; Michael P Manns; Rudolf Pichlmayr; Karl-Martin Koch; U Frei
The long-term course of hepatitis C after kidney transplantation.
Transplantation 1996;62(10):1417-21.
1996: M Meyer; R Richter; Reinhard Brunkhorst; Eike Wrenger; Peter Schulz-Knappe; A Kist; P Mentz; E G Brabant; Karl-Martin Koch; G Rechkemmer; Wolf-Georg Forssmann
Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects.
The American journal of physiology 1996;271(3 Pt 2):F489-97.
1996: Volkmar Lufft; Volker Kliem; Matthias Behrend; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression.
Transplantation 1996;62(3):421-3.
1996: S Krautzig; Gerhard Lonnemann; S Shaldon; Karl-Martin Koch
Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing.
Artificial organs 1996;20(7):798-800.
1996: Gerhard Lonnemann; S Krautzig; Karl-Martin Koch
Quality of water and dialysate in haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(6):946-9.
1996: OK Eberhard; Volker Kliem; Karl J Oldhafer; Hans J Schlitt; Rudolf Pichlmayr; Karl-Martin Koch; Reinhard Brunkhorst
How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation.
Transplantation 1996;61(9):1345-9.
1996: Marion Haubitz; Reinhard Brunkhorst; Eike Wrenger; P Froese; M Schulze; Karl-Martin Koch
Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996;16(2):158-62.
1996: Volker Kliem; Richard J Johnson; Charles E Alpers; A Yoshimura; William G Couser; Karl-Martin Koch; Jürgen Floege
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats.
Kidney international 1996;49(3):666-78.
1996: Reinhard Brunkhorst; Volker Kliem; Karl-Martin Koch
Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C.
Nephron 1996;72(3):465-7.
1996: J Schaeffer; Jürgen Floege; Karl-Martin Koch
Diagnostic aspects of beta 2-microglobulin amyloidosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 2():144-6.
1996: S Krautzig; S Linnenweber; R Schindler; S Shaldon; Karl-Martin Koch; Gerhard Lonnemann
New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 2():87-91.
1996: M Kruse; A Mahiout; Volker Kliem; P Kurz; Karl-Martin Koch; Reinhard Brunkhorst
Interleukin-1 beta stimulates glucose uptake of human peritoneal mesothelial cells in vitro.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996;16 Suppl 1():S58-60.
1996: Volker Kliem; W Thon; S Krautzig; M Kolditz; Matthias Behrend; Rudolf Pichlmayr; Karl-Martin Koch; U Frei; Reinhard Brunkhorst
High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1996;9(3):231-5.
1996: Volkmar Lufft; A Mahiout; stanley shaldon; Karl-Martin Koch; R Schindler
Retention of cytokine-inducing substances inside high-flux dialyzers.
Blood purification 1996;14(1):26-34.
1996: J Schaeffer; C J Olbricht; Karl-Martin Koch
Long-term performance of hemofilters in continuous hemofiltration.
Nephron 1996;72(2):155-8.
1996: R Schindler; S Krautzig; Volkmar Lufft; Gerhard Lonnemann; A Mahiout; M N Marra; S Shaldon; Karl-Martin Koch
Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(1):101-8.
1995: Jürgen Floege; W Kriz; M Schulze; M Susani; D Kerjaschki; A Mooney; William G Couser; Karl-Martin Koch
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
The Journal of clinical investigation 1995;96(6):2809-19.
1995: Jörg Radermacher; Karl-Martin Koch
Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
Clinical nephrology 1995;44 Suppl 1():S56-60.
1995: J Schaeffer; G Ehlerding; J Flöge; Karl-Martin Koch; stanley shaldon
Beta 2-microglobulin amyloidosis: why and how to look for it.
Clinical nephrology 1995;44 Suppl 1():S3-9.
1995: C J Olbricht; K Paul; Mathias Prokop; Ajay Chavan; CM Schaefer-Prokop; K Jandeleit; Karl-Martin Koch; Michael Galanski
Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography.
Kidney international 1995;48(4):1332-7.
1995: Karl-Martin Koch; R A Koene; D Messinger; O Quarder; P Scigalla
The use of epoetin beta in anemic predialysis patients with chronic renal failure.
Clinical nephrology 1995;44(3):201-8.
1995: R Schindler; C A Dinarello; Karl-Martin Koch
Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells.
Cytokine 1995;7(6):526-33.
1995: stanley shaldon; Karl-Martin Koch
Biocompatibility in hemodialysis: clinical relevance in 1995.
Artificial organs 1995;19(5):395-7.
1995: Gerhard Lonnemann; I Barndt; Volkhard Kaever; Marion Haubitz; R Schindler; S Shaldon; Karl-Martin Koch
Impaired endotoxin-induced interleukin-1 beta secretion, not total production, of mononuclear cells from ESRD patients.
Kidney international 1995;47(4):1158-67.
1995: Volker Kliem; Reinhard Brunkhorst; G Ehlerding; K Kühn; K H Neumann; Karl-Martin Koch
Prevention of glomerular hypertrophy and glomerulosclerosis in Milan normotensive rats by low-protein diet, but not by low-dose captopril treatment.
Nephron 1995;71(2):208-12.
1995: Gerhard Lonnemann; R Schindler; Volkmar Lufft; A Mahiout; S Shaldon; Karl-Martin Koch
The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(2):207-11.
1995: J Schaeffer; Jürgen Floege; G Ehlerding; Karl-Martin Koch
Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10 Suppl 3():4-8.
1995: U Frei; R Schindler; D Wieters; U Grouven; R Brunkhorst; Karl-Martin Koch
Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(7):1206-11.
1994: F Eitner; M Schulze; R Brunkhorst; Karl-Martin Koch; Jürgen Floege
On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: implications for the study of serologic phenomena in patients with immunoglobulin A nephropathy.
Journal of the American Society of Nephrology : JASN 1994;5(6):1400-6.
1994: Reinhard Brunkhorst; Eike Wrenger; S Krautzig; G Ehlerding; A Mahiout; Karl-Martin Koch
Clinical experience with home automated peritoneal dialysis.
Kidney international. Supplement 1994;48():S25-30.
1994: S E Dörge; P Roux-Lombard; J M Dayer; Karl-Martin Koch; U Frei; G Lonnemann
Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients.
Transplantation 1994;58(9):1000-8.
1994: Jürgen Floege; Karl-Martin Koch
Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
Clinical nephrology 1994;42 Suppl 1():S52-6.
1994: Reinhard Brunkhorst; Eike Wrenger; Karl-Martin Koch
Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis.
The Clinical investigator 1994;72(4):277-82.
1994: S Krautzig; Hans L Tillmann; Eike Wrenger; M Manns; Karl-Martin Koch; Reinhard Brunkhorst
Hepatitis-C virus (HCV) in peritoneal dialysis.
Clinical nephrology 1994;41(2):120.
1994: C J Olbricht; M Steinker; W Auch-Schwelk; C Bossaller; J Haas; Karl-Martin Koch
Effect of cyclosporin on kidney proteolytic enzymes in men and rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(1):22-6.
1994: Karl-Martin Koch
Clinical relevance of biocompatibility.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9 Suppl 2():126.
1994: P Herrmann; E Ritz; H Schmidt-Gayk; I Schäfer; J Geyer; B Nonnast-Daniel; Karl-Martin Koch; U Weber; W Hörl; A Haas-Wörle
Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial.
Nephron 1994;67(1):48-53.
1994: T Witte; C J Olbricht; Karl-Martin Koch
Interstitial nephritis associated with 5-aminosalicylic acid.
Nephron 1994;67(4):481-2.
1994: R Schindler; Gerhard Lonnemann; J Schäffer; stanley shaldon; Karl-Martin Koch; S Krautzig
The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis.
Nephron 1994;68(2):229-33.
1993: Torsten Witte; D Schaumann; R Hein; U Helmchen; K H Neumann; Karl-Martin Koch; HR Deicher; Reinhold E Schmidt
[Cyclophosphamide bolus therapy in lupus nephritis].
Deutsche medizinische Wochenschrift (1946) 1993;118(27-28):1005-10.
1993: Torsten Witte; D Schaumann; R Hein; K H Neumann; Karl-Martin Koch; HR Deicher; Reinhold E Schmidt
[Cyclophosphamide bolus therapy in lupus nephritis--status of the clinical study].
Immunität und Infektion 1993;21 Suppl 1():24-6.
1993: R Schindler; S Linnenweber; M Schulze; Martin Oppermann; Charles A Dinarello; S Shaldon; Karl-Martin Koch
Gene expression of interleukin-1 beta during hemodialysis.
Kidney international 1993;43(3):712-21.
1993: Reinhard Brunkhorst; Eike Wrenger; Karl-Martin Koch
[Clinical experiences with nocturnal intermittent peritoneal dialysis].
Deutsche medizinische Wochenschrift (1946) 1993;118(1-2):6-12.
1993: C J Olbricht; E Stark; U Helmchen; M Schulze; Reinhard Brunkhorst; Karl-Martin Koch
Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature.
Nephron 1993;64(1):139-41.
1993: Reinhard Brunkhorst; Eike Wrenger; C Malcharzik; G Brabant; Karl-Martin Koch
Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment.
Nephron 1993;64(2):275-81.
1993: C J Olbricht; H Irmler; E Gutjahr; Karl-Martin Koch
Effect of low-molecular-weight dextran on proteolytic and nonproteolytic lysosomal enzymes in isolated segments of rat proximal tubule.
Nephron 1993;64(2):262-7.
1992: U Frei; R Schindler; Cordula Matthies; Karl-Martin Koch
Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem.
The Journal of pharmacology and experimental therapeutics 1992;263(3):938-42.
1992: J Göbel; C J Olbricht; Gisela Offner; U Helmchen; H Repp; Karl-Martin Koch; U Frei
Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis.
Clinical nephrology 1992;38(6):299-304.
1992: Jürgen Floege; J Schäffer; Karl-Martin Koch; stanley shaldon
Dialysis related amyloidosis: a disease of chronic retention and inflammation?
Kidney international. Supplement 1992;38():S78-85.
1992: Gerhard Lonnemann; T C Behme; B Lenzner; Jürgen Floege; M Schulze; C K Colton; Karl-Martin Koch; stanley shaldon
Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
Kidney international 1992;42(1):61-8.
1992: Karl-Martin Koch
Dialysis-related amyloidosis.
Kidney international 1992;41(5):1416-29.
1992: P Schulzeck; C J Olbricht; Karl-Martin Koch
Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption.
The Clinical investigator 1992;70(2):99-104.
1992: B Nonnast-Daniel; R P Martin; O Lindert; A Mügge; J Schaeffer; H vd Lieth; E Söchtig; Michael Galanski; Karl-Martin Koch; W G Daniel
Colour Doppler ultrasound assessment of arteriovenous haemodialysis fistulas.
Lancet 1992;339(8786):143-5.
1992: U Frei; R Schindler; Karl-Martin Koch
Influence of antihypertensive therapy on renal function.
The Clinical investigator 1992;70 Suppl 1():S120-6.
1992: Gerhard Lonnemann; Jürgen Floege; stanley shaldon; Karl-Martin Koch
Blood-dialyzer interactions: their role in long-term complications of hemodialysis.
Contributions to nephrology 1992;100():155-71.
1992: U Frei; Reinhard Brunkhorst; R Schindler; U Bode; H Repp; Rudolf Pichlmayr; Karl-Martin Koch
Present status of kidney transplantation.
Clinical nephrology 1992;38 Suppl 1():S46-52.
1991: Reinhold E Schmidt; Torsten Witte; HR Deicher; K H Neumann; D Schaumann; Karl-Martin Koch
[Therapy of severe systemic lupus erythematosus].
Deutsche medizinische Wochenschrift (1946) 1991;116(49):1891-3.
1991: J Floege; A Bartsch; M Schulze; S Shaldon; Karl-Martin Koch; L C Smeby
Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects.
The Journal of laboratory and clinical medicine 1991;118(2):153-65.
1991: R Hein; K H Neumann; Karl-Martin Koch; HR Deicher; Reinhold E Schmidt
[Cyclophosphamide pulse therapy of systemic lupus erythematosus with renal involvement].
Immunität und Infektion 1991;19(2):57-8.
1991: Karl-Martin Koch; U Frei
Treatment of renal anemia, 1960-1990.
Advances in nephrology from the Necker Hospital 1991;20():19-30.
1991: J Bahlmann; K H Schöter; P Scigalla; H J Gurland; M Hilfenhaus; Karl-Martin Koch; F A Muthny; H H Neumayer; Wolfgang Pommer; E Quelhorst
Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study.
Contributions to nephrology 1991;88():90-106.
1991: Céline Granolleras; B Branger; stanley shaldon; B Nonnast-Daniel; Karl-Martin Koch; M Pollok; Conrad A Baldamus
Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration.
Contributions to nephrology 1991;88():144-8; discussion 149-51.
1991: Reinhard Brunkhorst; B Nonnast-Daniel; Karl-Martin Koch; U Frei
Hypertension as a possible complication of recombinant human erythropoietin therapy.
Contributions to nephrology 1991;88():118-25; discussion 126.
1991: Marion Haubitz; U Frei; U Rother; Reinhard Brunkhorst; Karl-Martin Koch
Cyclophosphamide pulse therapy in Wegener's granulomatosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991;6(8):531-5.
1990: Jürgen Floege; Wolfgang Burchert; Almuth Brandis; P Gielow; B Nonnast-Daniel; E Spindler; H Hundeshagen; stanley shaldon; Karl-Martin Koch
Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
Kidney international 1990;38(6):1169-76.
1990: T F Schorn; S Merscher; A Franz; C O Feddersen; U Frei; Rudolf Pichlmayr; Karl-Martin Koch
Disseminated tuberculosis after renal transplantation. A report of two cases.
Transplant international : official journal of the European Society for Organ Transplantation 1990;3(2):113-5.
1990: A Creutzig; Ludwig Caspary; B Nonnast-Daniel; J Bahlmann; K Kühn; Reinhard Brunkhorst; E Reimers; Karl-Martin Koch; K Alexander
Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin.
European journal of clinical investigation 1990;20(2):219-23.
1990: R Schindler; Gerhard Lonnemann; stanley shaldon; Karl-Martin Koch; Charles A Dinarello
Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement.
Kidney international 1990;37(1):85-93.
1990: Jürgen Floege; M Böddeker; Hilmar Stolte; Karl-Martin Koch
Urinary IgA, secretory IgA and secretory component in women with recurrent urinary tract infections.
Nephron 1990;56(1):50-5.
1990: Jürgen Floege; M F Wilks; M Soose; J Kotzerke; stanley shaldon; Karl-Martin Koch
Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function.
Nephron 1990;55(4):361-7.
1990: Marion Haubitz; M Schulze; Karl-Martin Koch
Increase of C-reactive protein serum values following haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(7):500-3.
1990: B Nonnast-Daniel; G Deschodt; Reinhard Brunkhorst; A Creutzig; J Bahlmann; S Shaldon; Karl-Martin Koch
Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(6):444-8.
1990: Wilfried Gwinner; U Frei; Cordula Matthies; Karl-Martin Koch; Hilmar Stolte
Glomerular barrier function for serum proteins in experimental heart failure.
Contributions to nephrology 1990;83():144-50.
1990: U Frei; B Nonnast-Daniel; J Schäffer; Karl-Martin Koch
Adverse cardiovascular effects of partial correction of renal anemia by recombinant human erythropoietin.
Contributions to nephrology 1990;82():72-8.
1990: U Frei; A Harms; R Bakovic-Alt; Rudolf Pichlmayr; Karl-Martin Koch
Calcium channel blockers for kidney protection.
Journal of cardiovascular pharmacology 1990;16 Suppl 6():S11-5.
1989: J Fauler; A Wiemeyer; K H Marx; K Kühn; Karl-Martin Koch; Jürgen C Frölich
LTB4 in nephrotoxic serum nephritis in rats.
Kidney international 1989;36(1):46-50.
1989: M Bingel; W Arndt; M Schulze; Jürgen Floege; S Shaldon; Karl-Martin Koch; Otto Götze
Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay.
Nephron 1989;51(3):320-4.
1989: Jürgen Floege; M Boeddeker; U Dreikhausen; Dietrich Peest; Karl-Martin Koch; Hilmar Stolte
Quantification of human urinary free secretory component, secretory and nonsecretory IgA by ELISA.
Clinical physiology and biochemistry 1989;7(3-4):165-75.
1989: Jürgen Floege; M F Wilks; Céline Granolleras; S Shaldon; Karl-Martin Koch
Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments.
Contributions to nephrology 1989;74():120-6.
1989: M Pollok; J Bommer; H J Gurland; Karl-Martin Koch; W Schoeppe; P Scigalla; Conrad A Baldamus
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.
Contributions to nephrology 1989;76():201-11; discussion 212-8.
1989: Jürgen Floege; Almuth Brandis; B Nonnast-Daniel; Mechthild Westhoff-Bleck; G Tiedow; R P Linke; Karl-Martin Koch
Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient.
Nephron 1989;53(1):73-5.
1989: S Shaldon; Gerhard Lonnemann; Karl-Martin Koch
Cytokine relevance in biocompatibility.
Contributions to nephrology 1989;70():227-36.
1989: Jürgen Floege; B Nonnast-Daniel; P Gielow; Almuth Brandis; E Spindler; H Hundeshagen; Karl-Martin Koch; S Shaldon
Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin.
Nephron 1989;51(3):444-7.
1989: Jürgen Floege; Céline Granolleras; S Merscher; G M Eisenbach; G Deschodt; C K Colton; S Shaldon; Karl-Martin Koch
Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful?
Nephron 1989;51(1):6-12.
1988: T Schorn; U Frei; H Brackmann; M Lorenz; P Vogt; B Wiese; Rudolf Pichlmayr; Karl-Martin Koch
Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function.
Transplantation proceedings 1988;20(3 Suppl 3):610-4.
1988: Charles A Dinarello; Karl-Martin Koch; S Shaldon
Interleukin-1 and its relevance in patients treated with hemodialysis.
Kidney international. Supplement 1988;24():S21-6.
1988: A Böcker; E Reimers; B Nonnast-Daniel; K Kühn; Karl-Martin Koch; P Scigalla; Klaus-Michael Braumann; Reinhard Brunkhorst; Dieter Böning
Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
Contributions to nephrology 1988;66():165-75.
1988: B Nonnast-Daniel; A Creutzig; K Kühn; J Bahlmann; E Reimers; Reinhard Brunkhorst; Ludwig Caspary; Karl-Martin Koch
Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation.
Contributions to nephrology 1988;66():185-94.
1988: S Shaldon; Charles A Dinarello; M Elie; Karl-Martin Koch
Interleukin-1 and biocompatibility in haemodialysis.
Contributions to nephrology 1988;62():128-31.
1988: J Flöge; Céline Granolleras; S Shaldon; Karl-Martin Koch
Dialysis-associated amyloidosis and beta-2-microglobulin.
Contributions to nephrology 1988;61():27-36.
1988: Gerhard Lonnemann; M Bingel; Jürgen Floege; Karl-Martin Koch; S Shaldon; Charles A Dinarello
Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis.
Kidney international 1988;33(1):29-35.
1988: M Bingel; Gerhard Lonnemann; Karl-Martin Koch; Charles A Dinarello; S Shaldon
Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes.
Nephron 1988;50(4):273-6.
1988: C J Olbricht; E Gutjahr; M Fink; Karl-Martin Koch
Potential role of lysosomal proteases in gentamicin nephrotoxicity.
Advances in experimental medicine and biology 1988;240():305-8.
1988: Jürgen Floege; M Wilks; S Shaldon; Karl-Martin Koch; L C Smeby
Beta 2-microglobulin kinetics during haemofiltration.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(6):784-9.
1988: S Shaldon; Karl-Martin Koch; Charles A Dinarello
Interleukin-1 activation and acute phase response during hemodialysis.
Contributions to nephrology 1988;61():18-26.
1988: S Shaldon; Charles A Dinarello; Karl-Martin Koch; Gerhard Lonnemann; M Bingel; Céline Granolleras; G Deschodt; B Branger; R Oulès; J Fourcade
Interleukin-1 and dialysis.
Advances in nephrology from the Necker Hospital 1988;17():423-34.
1988: Jürgen Floege; Céline Granolleras; Karl-Martin Koch; S Shaldon
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?
Nephron 1988;50(3):177-81.
1988: U Frei; M F Wilks; S Boehmer; N Crisp-Lindgren; R Schwarzrock; J C Stiekema; Karl-Martin Koch
Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(4):435-9.
1987: S Shaldon; M Elie; Karl-Martin Koch; Charles A Dinarello
Interleukin-1 stimulation in the ESRD patient: potential long-term consequences.
Transplantation proceedings 1987;19(5):4353-7.
1987: J Flöge; Céline Granolleras; L Smeby; H Göhl; Karl-Martin Koch; S Shaldon
Hydrophilic high flux polyamide membranes for beta-2-microglobulin removal.
ASAIO transactions / American Society for Artificial Internal Organs 1987;33(3):309-11.
1987: M Bingel; Gerhard Lonnemann; Karl-Martin Koch; Charles A Dinarello; S Shaldon
Enhancement of in-vitro human interleukin-1 production by sodium acetate.
Lancet 1987;1(8523):14-6.
1987: Charles A Dinarello; Gerhard Lonnemann; M Bingel; Karl-Martin Koch; S Shaldon
Biological consequences of monocyte activation during hemodialysis.
Contributions to nephrology 1987;59():1-9.
1987: J Flöge; Céline Granolleras; M Bingel; G Deschodt; B Branger; R Oules; Karl-Martin Koch; S Shaldon
Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1987;1(4):223-8.
1986: M Bingel; Gerhard Lonnemann; S Shaldon; Karl-Martin Koch; Charles A Dinarello
Human interleukin-1 production during hemodialysis.
Nephron 1986;43(3):161-3.
1983: D von Herrath; K Schaefer; M Hüfler; A Pauls; Karl-Martin Koch; H Göhl; L Ljunggren; P Gardiner
Complications of hemofiltration.
The International journal of artificial organs 1983;6(1):49-52.
1982: D von Herrath; K Schaefer; M Hüfler; A Pauls; Karl-Martin Koch
Complications of hemofiltration.
Contributions to nephrology 1982;32():146-53.